Read + Share
Popat S, Jung HA, Lee SY, Hochmair MJ, et al. Sequential afatinib and osimertinib in patients with EGFR mutation-positive NSCLC
and acquired T790M: A global non-interventional study (UpSwinG). Lung Cancer 2021;162:9-15.
PMID: 34649106
|
 |
|
Popat S, Jung HA, Lee SY, Hochmair MJ, et al. Sequential afatinib and osimertinib in patients with EGFR mutation-positive NSCLC
and acquired T790M: A global non-interventional study (UpSwinG). Lung Cancer 2021;162:9-15.
PMID: 34649106
|
|
|
|